Table 1. Hematologic data of beta-thalassemia patients.
| Parameters | Beta thalassemia intermedia n = 15 |
Beta thalassemia major n = 8 |
|---|---|---|
| RBC (106mm3) | 3.77 ± 0.65 | 3.07 ± 0.46 |
| Hb (g/dL) | 7.6 ± 0.71 | 6.5 ± 1.82 |
| VCM (fL) | 66.6 ± 8.82 | 74.1 ± 1.32 |
| Ret (%) | 7.1 ± 3.69 | 4.3 ± 1.8 |
| Hct (%) | 25.2 ± 1.79 | 22.5 ± 3.72 |
| HbF (%) | 10.5 ± 5.91 | 38.22 ± 40.05 |
| HbA (%) | 82.7 ± 5.38 | 57.7 ± 39.86 |
| HbA2(%) | 6.8 ± 1.16 | 2.9 ± 0.21 |
| WBC (103mm3) | 10.738 ± 5.984.66 | 14.300 ± 3.591.65 |
RBC, red blood cell; Hb, hemoglobin; MCV, mean corpuscular volume; Ret, reticulocyte; Hct, hematocrit; HbF, hemoglobin fetal; HbA, hemoglobin A, HbA2, hemoglobin A2; WBC, white blood cell. Data are presented as a mean and standard deviation. All BTM patients are under regular transfusion and iron chelation therapy. BTI patients are under non-regular transfusion and without iron chelation therapy.